Allogene (ALLO) Stock Price Today, Chart, Quote and News | baraka

A

Allogene (ALLO)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Allogene (ALLO)

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more

Open
USD1.71
High
USD1.72
Low
USD1.46
52 Week High
USD3.78
Monthly Return
26.50%
Revenue
--

Daily Vol.
8.18M
Avg. Daily Vol.
4.05M
Market Cap.
387M
52 Week Low
0.86
Annual Return
-8.50%

Stock News

Getting a doctor’s appointment will become even harder as a perfect storm hits the U.S. healthcare system

Getting a doctor’s appointment will become even harder as a perfect storm hits the U.S. healthcare system

MarketWatch

Generali Loads Up 5,000 MELI Shares Worth $10.6 Million

Generali Loads Up 5,000 MELI Shares Worth $10.6 Million

Yahoo

Tax season is here—4 reasons to file your return early

Tax season is here—4 reasons to file your return early

CNBC

Olympian Alysa Liu's training cost up to $1 million, her dad says—how experts say to approach spending on extracurriculars

Olympian Alysa Liu's training cost up to $1 million, her dad says—how experts say to approach spending on extracurriculars

CNBC

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.